Skip to main content
Premium Trial:

Request an Annual Quote

UPDATE: Agilent Licenses DNA Microarrays to Applied Biosystems

This article has been updated from a previous version

NEW YORK, Jan 24 - Agilent has licensed its custom in situ DNA microarrays to Applied Biosystems under a technology access agreement, the companies said Wednesday.

Applied Biosystems will use the microarrays for internal research and development only and did not gain a license to commercialize the Agilent arrays.

The parties did not disclose the financial terms of the agreement, and Agilent technologies declined to comment on details, citing a contractual arrangement with ABI.

“This deal is not going to be discussed,” said Agilent spokesman Doug Forsyth.

Applied Biosystems' comments were similarly succinct. " The agreement allows us to purchase affordable custom in situ synthesized oligonucleotide microarrays instead of manufacturing them in-house," said Applied Biosystems spokesman Jay Rhodes.

Since Agilent shipped its first large batch of custom DNA microarrays in September to Rosetta Inpharmatics, it has also signed deals to provide microarray s to DiaDexus, Paradigm Genetics, and Exelixis. Agilent distributes the Rosetta Resolver.

Earlier this month, Agilent licensed Incyte’s cDNA clone sets so it could make animal and human gene expression microarrays. Researchers using these arrays will have click-through access to Incyte’s LifeSeq gene-by-gene site so they can purchase additional information on specific genes.

Applied Biosystems said it is also continuing to develop systems for multiplexed DNA analysis through collaborations with 3M, Aclara BioSciences, Hyseq, and Illumina.

The Scan

Vaccine Update Recommended

A US Food and Drug Administration panel recommends booster vaccines be updated to target Omicron, CNBC reports.

US to Make More Vaccines for Monkeypox Available

The US is to make nearly 300,000 vaccine doses available in the coming weeks to stem the spread of human monkeypox virus, according to NPR.

Sentence Appealed

The Associated Press reports that Swedish prosecutors are appealing the sentence given to a surgeon once lauded for transplanting synthetic tracheas but then convicted of causing bodily harm.

Genome Biology Papers on COVID-19 Effector Genes, Virtual ChIP-seq, scDART

In Genome Biology this week: proposed COVID-19 effector genes, method to predict transcription factor binding patterns, and more.